Life Expectancy Biases in Clinical Decision Modeling

Medical Decision Making

Volumn 15, Issue 2, 1995, Pages 158-169

  Kuntz, Karen M ^a   Weinstein, Milton C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DECISION THEORY; LIFE EXPECTANCY; MATHEMATICAL MODEL; MEDICAL DECISION MAKING; SURVIVAL;

BIAS (EPIDEMIOLOGY); COST-BENEFIT ANALYSIS; DECISION TREES; HUMAN; LIFE EXPECTANCY; MODELS, STATISTICAL; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL ANALYSIS;

EID: 0028961320     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X9501500209     Document Type: Article

References (28)

1. Von Neumann J., Morgenstern O. Theory of Games and Economic Behavior, 2nd ed. Princeton, NJ: Princeton University Press, 1947.
2. Lehman EL Theory of Point Estimation. Belmont, CA: Wads-worth, 1991.
3. National Center for Health Statistics. Advance Report of Final Mortality Statistics. 1988. Monthly Vital Statistics Report, 1990; Volume 39.
4. Kaplan E.L., Meier P. Nonparametic estimation from incomplete observations J Am Statist Assoc. 1958; 53: 457-81.
5. Sonnenberg F.A., Beck JR Markov models in medical decision making: a practical guide. Med Decis Making. 1993; 13: 322-38.
6. Cox D.R., Oakes D. Analysis of Survival Data. New York: Chapman and Hall, 1984.
7. Breslow N.E., Day NE Statistical Methods in Cancer Research. Volume II: The Design and Analysis of Cohort Studies. New York: Oxford University Press, 1987.
8. Kalbtleisch J.D., Prentice RL The Statistical Analysis of Failure Time Data. New York: John Wiley & Sons, Inc., 1980.
9. Cox DR Regression models and life tables [with discussion]. J R Statist Soc (B). 1972;34:187-220.
10. Gompertz B. On the nature of the function expression of the law of human mortality. Philos Trans R Soc Lond. 1825; 115: 513-85.
11. Beck J.R., Kassirer J.P., Pauker SG A convenient approximation of life expectancy (the “DEALE”): I. Validation of the method. Am J Med. 1982; 73: 883-888.
12. Beck J.R., Pauker S.G., Gottlieb J.E., Klein K., Kassirer JP A convenient approximation of life expectancy (the “DEALE”): II. Use in medical decision-making Am J Med. 1982; 73: 889-97.
13. Keeler E., Bell R. New DEALEs: other approximations of life expectancy. Med Decis Making. 1992; 12: 307-11.
14. Killip T., Passamani E., Davis K., and the CASS Principal Investigators. Coronary artery surgery study (CASS): a randomized trial of coronary bypass surgery: eight years follow-up and survival in patients with reduced ejection fraction. Circulation 1985; 72(suppl V):V, 102-109.
15. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med. 1984; 311: 1333-9.
16. Varnauskas E., and the European Coronary Surgery Study Group. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study N Engl J Med. 1988; 319: 332-7.
17. Smltree, version 2.9, Roslyn, New York, James Hollenberg, 1989.
18. Barry M.J., Mulley A.G., Fowler F.J., Wennberg JW Watchful waiting vs immediate transurethral resection for symptomatic prostatism. The importance of patients' preferences. JAMA. 1988; 259: 3010-7.
19. Birkmeyer J.D., Marrin Cas, O'Connor GT Should patients with Bjork-Shiley valves undergo prophylactic replacement? Lancet. 1992; 340: 520-3.
20. Friedman L.S., Roberts M.S., Brett A.S., Marton KI Management of asymptomatic gallstones in the diabetic patient. Ann Intern Med. 1988;109: 913-9.
21. Goldman L., Weinstein M.C., Goldman P.A., Williams LW Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. JAMA. 1991; 265: 1145-51.
22. Hazen GB Factored stochastic trees: a tool for solving complex temporal medical decision models. Med Decis Making. 1993; 13: 227-36.
23. Keanev K.M., Tsevat J., Goldman L., Weinstein MC Cost-effectiveness of elective coronary angiography following acute myocardial infarction. Presented at the annual meeting of the Society of Medical Decision Making, Rochester, NY, NY,.Y,., October 1991.
24. Lee T.H., Fukui T., Weinstein M.C., Tosteson Ana, Goldman L. Cost-effectiveness of screening strategies for left main coronary artery disease in patients with stable angina. Med Decis Making. 1988; 8: 268-78.
25. Benbassat J., Zajicek G., van Oortmarssen G.J., Ben-dov I., Eckman M.H. Inaccuracies in estimates of life expectancies of patients with bronchial cancer in clinical decision making. Med Decis Making. 1993; 13: 237-44.
26. Tofler G.H., Muller J.E., Stone P.H., et al. Factors leading to shorter survival after acute myocardial infarction in patients ages 65 to 75 years compared with younger patients. Am J Cardiol. 1988; 62: 860-7.
27. Smith S.C., Gilpin E., Ahnve S., et al. Outlook after acute myocardial infarction in the very elderly compared with that in patients aged 65 to 75 years J Am Coll Cardiol. 1990; 16: 784-92.
28. Marcus F.I., Friday K., McCans J., et al. Age-related prognosis after acute mvocardial infarction (The Multicenter Diltiazem Postinfarction Trial) Am J Cardiol. 1990; 65: 559-66.